Skip to main content
. 2016 Sep 24;8(2):3581–3590. doi: 10.18632/oncotarget.12240

Figure 2. Response after two cycles of 6.0 GBq 177Lu-PSMA-617 RLT.

Figure 2

Axial 68Ga-PSMA PET B., D., F., H. and CT A., C., E., G. images of the base of the skull and the pelvis before (A, B, C, D) and after (E, F, G, H) two RLT cycles. Brain metastasis (A, B, E, F, arrow) and local recurrence (C, D, G, H, double arrow) demonstrate a >30% baseline to follow-up decrease in largest diameter and SUVmax. Inguinal lymph node metastasis (C, D, G, arrow) shows complete response on follow-up PET/CT.